Alan F. Denenberg
Lawyers
Filters
CytomX Therapeutics $58.3 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Revolution Medicines $500 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
SGH $175 million convertible notes offering and capped call transactions
The 2% convertible senior notes are due 2030
Netflix $1.8 billion senior notes offering
The investment-grade notes were issued in two tranches
IDEAYA Biosciences $302.5 million equity offering
The common stock is listed on the Nasdaq Global Select Market
Recursion Pharmaceuticals $230 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Nokia $2.3 billion acquisition of Infinera
We are advising Centerview Partners as financial adviser to Infinera
AssetMark strategic alliance with Morningstar and related acquisition of assets
We are advising AssetMark on the strategic alliance and acquisition of assets from Morningstar’s TAMP business
Tempus AI $410 million IPO
The stock is listed on the Nasdaq Global Select Market
Applied Materials $700 million senior notes offering
The investment-grade notes are due 2029